These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 15106187

  • 21. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
    Gordon M, Naidoo K, Akobeng AK, Thomas AG.
    Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Osmotic and stimulant laxatives for the management of childhood constipation.
    Gordon M, Naidoo K, Akobeng AK, Thomas AG.
    Cochrane Database Syst Rev; 2012 Jul 11; (7):CD009118. PubMed ID: 22786523
    [Abstract] [Full Text] [Related]

  • 24. Lactitol or lactulose in the treatment of chronic hepatic encephalopathy: results of a meta-analysis.
    Blanc P, Daures JP, Rouillon JM, Peray P, Pierrugues R, Larrey D, Gremy F, Michel H.
    Hepatology; 1992 Feb 11; 15(2):222-8. PubMed ID: 1531204
    [Abstract] [Full Text] [Related]

  • 25. Lactitol versus lactulose in the treatment of chronic hepatic encephalopathy. A double-blind, randomised, cross-over study.
    Morgan MY, Hawley KE, Stambuk D.
    J Hepatol; 1987 Apr 11; 4(2):236-44. PubMed ID: 3295020
    [Abstract] [Full Text] [Related]

  • 26. Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
    Morgan MY, Alonso M, Stanger LC.
    J Hepatol; 1989 Mar 11; 8(2):208-17. PubMed ID: 2654285
    [Abstract] [Full Text] [Related]

  • 27. Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.
    Jiang Q, Jiang XH, Zheng MH, Jiang LM, Chen YP, Wang L.
    Eur J Gastroenterol Hepatol; 2008 Nov 11; 20(11):1064-70. PubMed ID: 19047837
    [Abstract] [Full Text] [Related]

  • 28. Lactitol versus lactulose in the treatment of acute portal systemic encephalopathy (PSE). A controlled trial.
    Heredia D, Caballería J, Arroyo V, Ravelli G, Rodés J.
    J Hepatol; 1987 Jun 11; 4(3):293-8. PubMed ID: 3598162
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Dopamine agents for hepatic encephalopathy.
    Junker AE, Als-Nielsen B, Gluud C, Gluud LL.
    Cochrane Database Syst Rev; 2014 Feb 10; 2014(2):CD003047. PubMed ID: 24515383
    [Abstract] [Full Text] [Related]

  • 33. Is rifaximin better than nonabsorbable disaccharides in hepatic encephalopathy?: A meta-analysis.
    Cheng J, Chen Y, Cao W, Zuo G.
    Medicine (Baltimore); 2021 Dec 23; 100(51):e28232. PubMed ID: 34941089
    [Abstract] [Full Text] [Related]

  • 34. Benzodiazepine receptor antagonists for hepatic encephalopathy.
    Als-Nielsen B, Gluud LL, Gluud C.
    Cochrane Database Syst Rev; 2004 Dec 23; (2):CD002798. PubMed ID: 15106178
    [Abstract] [Full Text] [Related]

  • 35. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
    Gluud LL, Dam G, Borre M, Les I, Cordoba J, Marchesini G, Aagaard NK, Vilstrup H.
    Metab Brain Dis; 2013 Jun 23; 28(2):221-5. PubMed ID: 23275147
    [Abstract] [Full Text] [Related]

  • 36. Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose.
    Riggio O, Balducci G, Ariosto F, Merli M, Tremiterra S, Ziparo V, Capocaccia L.
    Hepatogastroenterology; 1990 Oct 23; 37(5):524-7. PubMed ID: 2253931
    [Abstract] [Full Text] [Related]

  • 37. [Lactitol and neomycin: monotherapy or combined therapy in the prevention and treatment of hepatic encephalopathy?].
    Scevola D, Zambelli A, Concia E, Perversi L, Candiani C.
    Clin Ter; 1989 Apr 30; 129(2):105-11. PubMed ID: 2525995
    [Abstract] [Full Text] [Related]

  • 38. Artificial and bioartificial support systems for liver failure.
    Liu JP, Gluud LL, Als-Nielsen B, Gluud C.
    Cochrane Database Syst Rev; 2004 Apr 30; 2004(1):CD003628. PubMed ID: 14974025
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Rifaximin for the treatment of hepatic encephalopathy.
    Lawrence KR, Klee JA.
    Pharmacotherapy; 2008 Aug 30; 28(8):1019-32. PubMed ID: 18657018
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.